Question: are lantus and basaglar biosimilar?
Answer: Basaglar is an insulin glargine injection, approved in Dec 2015 and manufactured by Eli Lilly. Basaglar is a "follow-on" product to Lantus (insulin glargine injection), made by Sanofi-Aventis. However, the FDA does not consider Basaglar a biosimilar to Lantus.